

Product description
MAP kinase activating death domain(MADD) Homo sapiens Tumor necrosis factor alpha (TNF-alpha) is a signaling molecule that interacts with one of two receptors on cells targeted for apoptosis. The apoptotic signal is transduced inside these cells
Source
Rabbit
Applications
WB,IHC,IF,ELISA
Reactivity
Human,Mouse,Rat
Dilution
WB: 1/500 - 1/2000. IHC: 1/100 - 1/300. IF: 1/200 - 1/1000. ELISA: 1/5000. Not yet tested in other applications.
Storage
-20°C/1 year
Specificity
MADD Polyclonal Antibody detects endogenous levels of MADD protein.
Source/Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Immunogen
The antiserum was produced against synthesized peptide derived from human MADD. AA range:751-800
Uniprot No
Q8WXG6
Alternative names
MADD; DENN; IG20; KIAA0358; MAP kinase-activating death domain protein; Differentially expressed in normal and neoplastic cells; Insulinoma glucagonoma clone 20; Rab3 GDP/GTP exchange factor
Form
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Clonality
Polyclonal
Background
MAP kinase activating death domain(MADD) Homo sapiens Tumor necrosis factor alpha (TNF-alpha) is a signaling molecule that interacts with one of two receptors on cells targeted for apoptosis. The apoptotic signal is transduced inside these cells
Other
Gene_name: MADD ; Protein_name: MAP kinase-activating death domain protein; Expression: Brain,Fetal liver,Insulinoma,Liver,Testis,
Mol.Wt (Da)
183 kD
Concentration
1 mg/ml
-
Promotion
-
Order
-
Online message
-
Help center